Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance

Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance

Recent insight in the genomic landscape of newly diagnosed multiple myeloma (NDMM) and its precursor conditions, monoclonal gammopathy of uncertain significance (MGUS), and smoldering myeloma have allowed the identification of patients with precursor conditions with a high risk of progression. These...

Full description

Bibliographic Details
Main Authors: Mateo Mejia Saldarriaga, Walaa Darwiche, David Jayabalan, Jorge Monge, Cara Rosenbaum, Roger N. Pearse, Ruben Niesvizky, Mark Bustoros
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
myeloma and other plasma cell dyscrasias
resistance
molecular subclassification
smoldering myeloma (SMM)
MGUS
risk stratification
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1020011/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1020011/full

Similar Items